Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,211

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,841

Class I recallsReasonable probability of serious health consequences

24,366

Class II recallsTemporary or medically reversible health consequences

2,892

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,073 recalls

Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/frutas-y-hortalizas-del-sur-sa-expands-recalls-include-additional-lots-great-value-frozen-organicPublished October 2, 2026

Most affected stateHawaii 200 recalls mention this state

State: ND ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated October 3, 2026 ET

Summary (Year to date)

1,714 recalls have been announced year to date.
Sep 2026 was 3% higher than the previous complete period (Aug 2026: 182).
The highest complete period was Jun 2026 (297).
Oct 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,366
Class I	9,841
Class III	2,892
Not Yet Classified	2

Download CSV

Recalls by class
Class	Recalls
Class II	24,366
Class I	9,841
Class III	2,892
Not Yet Classified	2

FDA Recall Terminated Historical recordClass II

Ropinirole hydrochloride tablets, USP 4 mg, 100-count bottle (NDC 0378-5504-01), Rx only, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A. Made in India

by Mylan Pharmaceuticals Inc.

Reason: Labeling: Label Error on Declared Strength- Unopened bottles of Ropinirole USP 3 mg tablets was found to be incorrectly labeled as Ropinirole USP 4 mg tablets..
Published: June 5, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Lisinopril Tablets, USP, 30 mg, Rx only, 100 tablets, NDC 65862-041-01 Manufactured for: Aurobindo Pharma USA Inc. 2400 Route 130 North, Dayton, NJ 08810 Manufactured by: Aurobindo Pharma Limited Hyderabad- 500 072 India

by Aurobindo Pharma USA Inc

Reason: Labeling: Label Error on Declared Strength: Incorrect strength on side display panel of label
Published: June 5, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Camrese(TM) (Levonorgestrel/Ethinyl Estradiol Tablets), 0.15 mg/0.03 mg and Ethinyl Estradiol 0.01 Tablets, 2 Extended-Cycle Tablet Dispensers (NDC 0093-3134-82) and 1 Extended-Cycle Tablet Dispenser NDC 0093-3134-91), 91 Tablets Each, Rx only, TEVA Womens Health Inc., Subsidiary of TEVA Pharmaceuticals, Inc., Sellersville, PA

by Teva Pharmaceuticals USA, Inc.

Reason: Failed Impurity/Degradation Specifications; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) detected during impurity testing
Published: June 5, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Seasonale(R) (Levonorgestrel/Ethinyl Estradiol Tablets), 0.15 mg/0.03 mg, 3 extended-cycle tablet dispensers, 91 tablets each, Rx only, TEVA Women Health, Inc., Subsidiary of TEVA Pharmaceuticals USA, Inc., Sellersville, PA NDC 51285-058-66

by Teva Pharmaceuticals USA, Inc.

Reason: Failed Impurity/Degradation Specification; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) detected during impurity testing
Published: June 5, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Pyridoxine 100mg/ml Inj MDV, 1X30 ml 30 day expiration,

by Nora Apothecary and Alternative Therapies, Inc.

Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Published: June 5, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Meperidine 100mg/ml MDV, 5ml 90 day expiration,

by Nora Apothecary and Alternative Therapies, Inc.

Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Published: June 5, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Lidocaine 2% Inj MDV, 20 ml 30 day expiration,

by Nora Apothecary and Alternative Therapies, Inc.

Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Published: June 5, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

M.I.C.+B12 Inj MDV: 3x50ml, 4x50 ml 90 day expiration,

by Nora Apothecary and Alternative Therapies, Inc.

Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Published: June 5, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Glutathione 200mg/ml Inj SDV: 3x50ml 14 day expiration, 1x50ml 21 day expiration

by Nora Apothecary and Alternative Therapies, Inc.

Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Published: June 5, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Gentamicin 24mg/60ml Irrigation, 15x60ml Syr Irrigation, 14 day expiration,

by Nora Apothecary and Alternative Therapies, Inc.

Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Published: June 5, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Hydroxyprogesterone Inj 250mg/ml MDV, 5 ml Intramuscular, 30 day expiration,

by Nora Apothecary and Alternative Therapies, Inc.

Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Published: June 5, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Methylcobalamin Inj 25mg/ml Syr: 8x0.06mlsyr, 10x0.06 ml syr, 12x0.06 ml syr Subcutaneous, 30 and 90 day expiration,

by Nora Apothecary and Alternative Therapies, Inc.

Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Published: June 5, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Methylcobalamin Inj 2.5mg/ml MDV, 10 ml Subcutaneous, 90 day expiration,

by Nora Apothecary and Alternative Therapies, Inc.

Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Published: June 5, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Methylcobalamin 5mg/ml Inj Syr, 10x0.4syr Subcutaneous, 90 day expiration,

by Nora Apothecary and Alternative Therapies, Inc.

Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Published: June 5, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Methylcobalamin Inj 5mg/ml MDV: 5 ml, 10 ml, 12 ml, 20 ml Subcutaneous, 90 day expiration,

by Nora Apothecary and Alternative Therapies, Inc.

Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Published: June 5, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Methylcobalamin Inj 1mg/ml MDV, 10 ml, 15 ml, 20 ml, 30 ml, 4x30 ml Subcutaneous, 90 day expiration,

by Nora Apothecary and Alternative Therapies, Inc.

Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Published: June 5, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Hydroxycobalamin Inj 2500 mcg/ml MDV, 2x30ml Subcutaneous, 90 day expiration,

by Nora Apothecary and Alternative Therapies, Inc.

Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Published: June 5, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Hydroxycobalamin Inj 1 mcg/ml MDV, 2x30ml Subcutaneous, 90 day expiration,

by Nora Apothecary and Alternative Therapies, Inc.

Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Published: June 5, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Hydroxycobalamin Inj 1000mcg/ml MDV: 10 ml, 15 ml, 20 ml, 30 ml Subcutaneous, 90 day expiration,

by Nora Apothecary and Alternative Therapies, Inc.

Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Published: June 5, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

HCG Inj 500un/ml MDV, 5 ml Subcutaneous, 30 day expiration,

by Nora Apothecary and Alternative Therapies, Inc.

Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Published: June 5, 2013
Distribution: Nationwide

View recall →

Data last updated: October 3, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.